Truvestments Capital LLC Acquires Shares of 1,058 Omega Healthcare Investors, Inc. (NYSE:OHI)

Truvestments Capital LLC acquired a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, Holdings Channel reports. The fund acquired 1,058 shares of the real estate investment trust’s stock, valued at approximately $43,000.

Several other large investors also recently bought and sold shares of the stock. Daiwa Securities Group Inc. boosted its stake in Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Omega Healthcare Investors by 6.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock valued at $155,893,000 after buying an additional 240,006 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock valued at $127,831,000 after buying an additional 272,299 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Omega Healthcare Investors by 4.6% in the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust’s stock valued at $110,971,000 after buying an additional 143,521 shares during the last quarter. Finally, LSV Asset Management raised its holdings in shares of Omega Healthcare Investors by 0.7% in the second quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust’s stock valued at $67,411,000 after buying an additional 14,000 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a report on Thursday, October 31st. Royal Bank of Canada upped their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Scotiabank upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Berenberg Bank assumed coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 target price for the company. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $40.00.

Insider Buying and Selling at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by corporate insiders.

Omega Healthcare Investors Trading Down 0.2 %

Shares of Omega Healthcare Investors stock opened at $40.68 on Thursday. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a market cap of $10.98 billion, a PE ratio of 29.91, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. The company has a 50-day moving average of $40.60 and a two-hundred day moving average of $37.21.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.59%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.